These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3260050)

  • 1. Results of a one-year open trial of cyclosporine in ten patients with severe myasthenia gravis.
    Goulon M; Elkharrat D; Lokiec F; Gajdos P
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):211-7. PubMed ID: 3260050
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunopharmacological treatment in myasthenia gravis.
    Nyberg-Hansen R; Gjerstad L
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):201-10. PubMed ID: 3289206
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
    Hohlfeld R; Wekerle H
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of an open trial of cyclosporine in a group of steroido-dependent myasthenic subjects.
    Antonini G; Bove R; Filippini C; Millefiorini M
    Clin Neurol Neurosurg; 1990; 92(4):317-21. PubMed ID: 1963821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific overview of myasthenia gravis and an assessment of the role of plasmapheresis.
    Tindall RS
    Prog Clin Biol Res; 1982; 106():113-42. PubMed ID: 6757936
    [No Abstract]   [Full Text] [Related]  

  • 6. The in vitro effects of D-penicillamine upon anti-AChR production by thymic and peripheral blood lymphocytes from patients with myasthenia gravis.
    Scadding GK; Calder L; Newsom-Davis J
    Muscle Nerve; 1983; 6(9):656-60. PubMed ID: 6606776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myasthenia gravis and autoimmunity].
    Ergüven S
    Mikrobiyol Bul; 1986 Apr; 20(2):105-8. PubMed ID: 3773796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of severe myasthenia gravis with cyclosporin. A 12-month open trial].
    Goulon M; Elkharrat D; Gajdos P
    Presse Med; 1989 Feb; 18(7):341-6. PubMed ID: 2522627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciclosporin in the treatment of myasthenia gravis.
    Tindall RS; Phillips JT; Rollins JA; Greenlee RG; Wells L; Belendiuk G
    Monogr Allergy; 1988; 25():135-47. PubMed ID: 3173362
    [No Abstract]   [Full Text] [Related]  

  • 10. Myasthenia gravis.
    Sen S; Banerjee TK
    J Assoc Physicians India; 1995 Jul; 43(7):487-93. PubMed ID: 8713224
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ocular involvement in MuSK antibody-positive myasthenia gravis].
    Bau V; Hanisch F; Hain B; Zierz S
    Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine: therapeutic effects in rheumatic diseases.
    Amor B; Dougados M
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):218-23. PubMed ID: 3289207
    [No Abstract]   [Full Text] [Related]  

  • 13. Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprine.
    Hohlfeld R; Toyka KV; Besinger UA; Gerhold B; Heininger K
    Ann Neurol; 1985 Mar; 17(3):238-42. PubMed ID: 3873207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte activation in experimental autoimmune myasthenia gravis.
    De Baets MH; Einarson B; Lindstrom JM; Weigle WO
    J Immunol; 1982 May; 128(5):2228-35. PubMed ID: 6977589
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of acetylcholine receptor antibodies in myasthenia gravis].
    Zeitlhofer J; Maida EM; Mamoli B; Mayr N
    Wien Med Wochenschr; 1986 Jul; 136(13):329-32. PubMed ID: 3765651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Cervera C; Armengol M
    Neurology; 2005 May; 64(9):1641-3. PubMed ID: 15883336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to recognize an antibody-mediated autoimmune disease: criteria.
    Drachman DB
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():183-6. PubMed ID: 2183310
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amount of circulating acetylcholine receptor antibodies in the course of myasthenia, following thymectomy and in immunosuppressive therapy].
    Patzold U; Kalies I; Haas J; Ginda EM
    Nervenarzt; 1984 Aug; 55(8):426-31. PubMed ID: 6483064
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acetylcholine receptor antibodies in myasthenia gravis].
    Yakirevich V; Snir E; Brener T; Borenstein N; Vidne BA
    Harefuah; 1983 Apr; 104(7):269-70. PubMed ID: 6618324
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppression of experimental autoimmune myasthenia gravis by azathioprine. II. Evaluation of immunological mechanism.
    Tarrab-Hazdai R; Abramsky O; Fuchs S
    J Immunol; 1977 Aug; 119(2):702-6. PubMed ID: 886191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.